Immunomodulators for severe coronavirus disease-2019 in transplant patients: Do they increase the risk of secondary infection?

Maria A MendozaNischal Ranganath Supavit Chesdachai Zachary A Yetmar Raymund R RazonableOmar Abu Saleh

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2023)

The use of immunomodulators in transplant patients with severe COVID-19 was not significantly associated with an increased risk of secondary infections. Secondary infections were associated with higher risk of all-cause mortality. Future studies of larger cohorts are needed to explore the effect of immunomodulators on survival among transplant patients with COVID-19.

Keyphrases

coronavirus disease
end stage renal disease
sars cov
ejection fraction
newly diagnosed
current status
patient reported outcomes